| scholarly article | Q13442814 |
| P50 | author | Tamara Djuric | Q51746634 |
| Dragan Alavantić | Q51746641 | ||
| Stankovic A. | Q57828878 | ||
| Maja Zivkovic | Q57962162 | ||
| P2093 | author name string | Ana Kolaković | |
| Vesna Selaković | |||
| Djole Jekić | |||
| P2860 | cites work | Matrix metalloproteinases | Q28140451 |
| The collagen substrate specificity of human neutrophil collagenase | Q28288667 | ||
| Measurement of matrix metalloproteinases and tissue inhibitors of metalloproteinases in blood and tissues. Clinical and experimental applications | Q33692926 | ||
| Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture | Q35993294 | ||
| Increased tissue factor, MMP-8, and D-dimer expression in diabetic patients with unstable advanced carotid atherosclerosis. | Q36536326 | ||
| Serum matrix metalloproteinase-8 concentrations are associated with cardiovascular outcome in men. | Q43769669 | ||
| Matrix metalloproteinase-8 and tissue inhibitor of metalloproteinase-1 in serum do not reflect the analytes circulating in blood | Q44075976 | ||
| Increased matrix metalloproteinase-8 and -9 activity in patients with infarct rupture after myocardial infarction | Q44084472 | ||
| Evaluation of serum matrix metalloproteinases as biomarkers for detection of neurological symptoms in carotid artery disease. | Q45916564 | ||
| Ultrasound-detected carotid plaque as a screening tool for advanced subclinical atherosclerosis | Q46807082 | ||
| Unstable carotid plaques exhibit raised matrix metalloproteinase-8 activity | Q47266111 | ||
| Assessment of matrix metalloproteinase (MMP)-2, MMP-8, MMP-9, and their inhibitors, the tissue inhibitors of metalloproteinase (TIMP)-1 and TIMP-2 in obese children and adolescents | Q48026206 | ||
| Intraplaque MMP-8 levels are increased in asymptomatic patients with carotid plaque progression on ultrasound. | Q48711796 | ||
| Correlates of serum matrix metalloproteinase-8 (MMP-8) concentrations in nondiabetic subjects without cardiovascular disease. | Q51479961 | ||
| C-reactive protein promotes cardiac fibrosis and inflammation in angiotensin II-induced hypertensive cardiac disease. | Q54441285 | ||
| Expression of neutrophil collagenase (matrix metalloproteinase-8) in human atheroma: a novel collagenolytic pathway suggested by transcriptional profiling | Q74623079 | ||
| Plasma matrix metalloproteinase-8 concentrations are associated with the presence and severity of coronary artery disease | Q81126412 | ||
| High plasma levels of matrix metalloproteinase-8 in patients with unstable angina | Q84393433 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | atherosclerosis | Q12252367 |
| P304 | page(s) | 246-251 | |
| P577 | publication date | 2010-01-01 | |
| P1433 | published in | Journal of Clinical Laboratory Analysis | Q15754724 |
| P1476 | title | Plasma levels of matrix metalloproteinase-8 in patients with carotid atherosclerosis | |
| P478 | volume | 24 |
| Q48237580 | Floating solid cellulose nanofibre nanofoams for sustained release of the poorly soluble model drug furosemide |
| Q36302470 | Low MMP-8/TIMP-1 reflects left ventricle impairment in takotsubo cardiomyopathy and high TIMP-1 may help to differentiate it from acute coronary syndrome |
| Q50916304 | Matrix Metalloproteinase Inhibitors as Investigational and Therapeutic Tools in Unrestrained Tissue Remodeling and Pathological Disorders. |
| Q47223491 | Matrix Metalloproteinases, Vascular Remodeling, and Vascular Disease |
| Q36009930 | Matrix metalloproteinase inhibitors as investigative tools in the pathogenesis and management of vascular disease |
| Q35161646 | Matrix metalloproteinases in atherosclerosis: role of nitric oxide, hydrogen sulfide, homocysteine, and polymorphisms |
| Q91259885 | Matrix metalloproteinases in pro-atherosclerotic arterial remodeling |
| Q34700220 | Salivary biomarkers for detection of systemic diseases |
Search more.